Inhibitors of L-type calcium channels show therapeutic potential for treating SARS-CoV-2 infections by preventing virus entry and spread
M. R. Straus, M. Bidon, T. Tang, J. A. Jaimes, G. Whittaker, S. Daniel
This study tests L-type calcium channel blockers for inhibiting SARS-CoV-2 infection in cell culture, finding that felodipine and nifedipine limit virus entry and infection with minimal toxicity.
ACS Infectious Diseases · Sep 9, 2021Peer-reviewedMicrobiology